Cost-utility analysis of eptinezumab for migraine prevention in Taiwan.

ABSTRACT:

SUBMITTER: Chan CS 

PROVIDER: S-EPMC12860139 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature